Applied Clinical Trials
February 01, 2012
Issue PDF
21
2
TRIAL DESIGN : Enrollment is More Than a Numbers Game REGULATORY : Late Phase PK Collection Also in this issue : Protocol Design and Study Management, Effects of Europe?s Economic Turbulence, Ready for Big Data?, Outcomes Assessments
February 01, 2012
Sponsor/CRO Key to Business Relationships
21
2
The best relationships between sponsors and contractors are those that are well defined from the outset.
February 01, 2012
News
21
2
PPD has begun training its Clinical Research Associates in a virtual classroom.
February 01, 2012
Business News
21
2
Industry news focusing on the people and organizations who work in the clinical trials profession.
February 01, 2012
View from Brussels
21
2
Europe's struggling economies may have unexpected effects on the pharmaceutical sector.
February 01, 2012
A Closing Thought
21
2
All measurements and outcomes need to reflect what is happening with the patient.
February 01, 2012
View from Washington
21
2
FDA wants sponsors to build quality into protocols, adopt risk-based strategies to streamline trials.
February 01, 2012
Sponsor/CRO Key to Business Relationships
21
2
Five key pieces to a lasting and successful sponsor/CRO relationship.
February 01, 2012
Sponsor/CRO Key to Business Relationships
21
2
PAREXEL's Neal Mantick discusses the strategic advantage of the transition from clinical research to commercial.
February 01, 2012
News
21
2
Pzizer's Craig Lipset answers questions about the ongoing REMOTE trial.
February 01, 2012
CTI Insights
21
2
Vendors have developed systems for massive databases, but are we data ready?
February 01, 2012
Feature Article
21
2
Partnering with CROs and using a blinded independent central review can increase trial success.
February 01, 2012
Global News
21
2
A British Medical Journal survey suggests that misconduct in research is not going away.
February 01, 2012
Feature Article
21
2
Collecting PK data in late phase trials led to alleviating additional trials, drug approval, and better dosing.